Atea Pharmaceuticals's total assets for Q3 2024 were $490.96M, a decrease of -3.81% from the previous quarter. AVIR total liabilities were $32.44M for the fiscal quarter, a -4.36% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.